PanCancer Immune Profiling Panel

Human and Mouse

The PanCancer Immune Profiling gene panel includes 770 genes from 24 immune cell types, common checkpoint inhibitors, CT antigens and genes for immune response. Covering both the adaptive and innate immune systems, this panel is a complete tool to study immune response in cancer.

Benefits

01

Comprehensive profiling of immune response optimized for immuno-oncology research.

02

Identify tumor-infiltrating lymphocytes (TILs) for the tumor microenvironment.

03

Assess mechanistic pathway activity for single or combination studies.

Details & data

PanCancer Immune Profiling: Exploring immune response to cancer

  • 770 cancer pathway genes
  • 24 different immune cell types
  • 30 CT antigens
  • 500+ genes covering innate and adaptive immune response

 

Category/PathwayHuman genes
Mouse genes
Representative Hallmarks
Adaptive Immunity
104
112Avoiding immune destruction
Humoral Immunity
4157Avoiding immune destruction
Inflammation
66
152Tumor-promoting inflammation
Innate Immunity
200225Tumor-promoting inflammation

Genes in panel

Need CLIA Certified NanoString Services?

Fill out this form and one of our scientists will contact you.

Pricing

mRNA > PanCancer Immune Profiling Panel

$5,459.00

Up to 12 samples per order analyzed.

$

Please add some options to render this input.

Step 3

Price

Number of samples
$5,459.00*
*price includes reagents
REQUEST A QUOTE
SKU: pancancer-immune-profiling. Categories: , , . Tag:
Genes: ..
.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Aliases: .................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Tag: